Apex Biotechnology Corp. - Taiwan
Figures in New Taiwan dollars.
2026 2025
Revenue NT$141,377,000 NT$186,373,000
Jan-Mar Revenue NT$519,723,000 NT$558,753,000
Source: Taiwan Stock Exchange This content was automatically published based on data and/or text from the original source. For feedback, write to singaporeeditors@dowjones.com.